Bogdan Lesyng Selected Research

ITB 301

10/2011

A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bogdan Lesyng Research Topics

Disease

5	Neoplasms (Cancer) 01/2016 - 12/2006
1	Cytokine Release Syndrome 01/2021
1	COVID-19 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Carcinogenesis 06/2012
1	Glioma (Gliomas) 06/2012
1	Ovarian Neoplasms (Ovarian Cancer) 10/2011

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 01/2021 - 01/2016
2	cinnamic acidIBA 01/2016 - 01/2014
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	2- cyano- N- (1- phenylethyl)- 3- (pyridin- 2- yl)acrylamideIBA 01/2014
1	2- cyano- N- (1,4- diphenylbutyl)- 3- (3- bromopyridin- 2- yl)acrylamideIBA 01/2014
1	degrasynIBA 01/2014
1	AmidesIBA 01/2014
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 06/2012
1	caffeic acidIBA 06/2012
1	ITB 301IBA 10/2011
1	GlycosidesIBA 10/2011
1	TubulinIBA 10/2011
1	GenisteinIBA 10/2011
1	Deoxyglucose (2 Deoxy D glucose)IBA 12/2006
1	Glucose (Dextrose)FDA LinkGeneric 12/2006

Therapy/Procedure

1	Therapeutics 06/2012